mercredi 2 octobre 2019

Onco Actu du 2 octobre 2019


1. BIOLOGIE



How cancer vesicles breach the blood-brain barrier [NIH]











2.6 ETIOLOGIE - ENVIRONNEMENT



Can herbicides cause breast cancer? Purdue and INSERM scientists discover a piece to the puzzle. [Purdue University]











3.1.1 PRÉVENTION - TABAC - E-CIGS



Mysterious vaping deaths: Why US officials are focusing on flavour [Nature]










3.8 PRÉVENTION - ALIMENTATION



Foods High in Vitamin A May Help Ward Off Skin Cancer [NY Times]











4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC



What is overdiagnosed cancer? And why does it matter? [Croakey]










4.10 DÉP., DIAG. & PRONO. - POUMON



Screening for lung cancer based on risk could save lives [University of Michigan]










5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



A promising antibody [Kiel University]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates [Cellectis]











5.12.5 IMMUNOTHÉRAPIES - PHARMA



ElevateBio founds HighPassBio to develop Fred Hutch cell therapy [Fierce Biotech]











5.17 TRAITEMENTS - RADIOTHÉRAPIE



Gut bacteria ‘fingerprint’ predicts radiotherapy side effects [Imperial College London]










5.2 PHARMA



Sanofi's story needs to be 'better told,' new CEO says [Biopharma Dive]











5.3 TRAITEMENTS - FDA, EMA, NICE...



Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process [STAT]











Patient-focused drug development: New FDA draft guidance delves into what’s important [EndPoints]











Trump will pick Stephen Hahn as his next FDA commissioner — reports [EndPoints]











5.6 ESMO



ESMO 2019 may be over, but the market battles it set up are just getting started [Fierce Pharma]











ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More [Xconomy]










5.6.13 ESMO - PROSTATE



First Prostate Cancer Therapy to Target Genes Delays Cancer Progression [Northwestern University]











Esmo 2019 – Clovis is running out of waves to catch [Vantage]











6.6 PUBLICATIONS



Two-thirds of researchers report ‘pressure to cite’ in Nature poll [Nature]











6.7.1 IA/BIOINFORMATIQUE



Bringing together deep bioscience and AI to help patients worldwide: Novartis and Microsoft work to reinvent treatment discovery and development [Microsoft]